Navigation Links
Siemens Delivers Flash Speed, Lowest Dose to Arnold Palmer Hospital for Children
Date:10/28/2009

for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 49,000 employees worldwide and operates in over 130 countries. In fiscal year 2008 (to September 30), the Sector posted revenue of 11.2 billion euros and profit of 1.2 billion euros. For further information please visit: www.siemens.com/healthcare.

Arnold Palmer Hospital for Children, supported by the Arnold Palmer Medical Center Foundation, is a 158-bed facility dedicated exclusively to the needs of children. Located in Orlando, Arnold Palmer Hospital provides expertise in pediatric specialties such as cardiac care, craniomaxillofacial surgery, emergency and trauma care, gastroenterology, nephrology, neurology, oncology, orthopedics, pulmonology and sports medicine. Visit www.arnoldpalmerhospital.com to learn more about all of our specialties.

SOURCE Siemens Healthcare


'/>"/>
SOURCE Siemens Healthcare
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Siemens Corporate Research Develops RAPID2 System for Fast Discovery of Discriminative Pathogen Signatures
2. Siemens Introduces New Standard of Care for Breast Ultrasound
3. Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests
4. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
5. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
6. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
7. Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
8. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
9. Varian, Inc. Delivers a Productivity Increase of Up to 100% With Its 710-ES Series ICP-OES
10. Ethicon Endo-Surgery Launches New Echelon Flex(TM) Endopath(R) Stapler That Delivers Echelon(TM) Compression, Now With Natural Articulation
11. Hoviones TwinCaps(R) Inhaler Delivers Successfully in Phase III Clinical Trials for Influenza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... 4 Drs. Neal Shore and E. David Crawford ... additional analysis of secondary end points of biochemical recurrence ... (monthly degarelix for injection) or monthly leuprolide in prostate ... Prostate cancer patients who received FIRMAGON 240/80 mg/month had ...
(Date:12/4/2009)... WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: ... Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine ... antidepressants in adults with Major Depressive Disorder (MDD). SEROQUEL ... by the FDA to treat both major depressive disorder ...
(Date:12/3/2009)... NEW YORK, Dec. 3 Guidepoint Global, LLC , ... their Sleep Apnea Tracker, a monthly longitudinal data release that ... Sleep Apnea market. ,, The Sleep Apnea Tracker captures ... sold in the United States from 15 different equipment providers ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2U of A and leading German researchers team up to build oil sands sustainability 10182 1U of A and leading German researchers team up to build oil sands sustainability 10182 2Study in Spain and Romania confirms radon as second leading cause of lung cancer 10179 1Study in Spain and Romania confirms radon as second leading cause of lung cancer 10179 2Study in Spain and Romania confirms radon as second leading cause of lung cancer 10179 3ShowerBuddy Affordable Accessible Bathing 5101 1ShowerBuddy Affordable Accessible Bathing 5101 2
... Opening celebrated with inaugural Symposium on Biofilms, ... 29 ,BASF today announced the official launch ... University. The Advanced Research Initiative at,Harvard University ... specifically to drive new frontiers of scientific,discovery. ...
... April 29 InfraReDx, Inc. announced,today that ... U.S. Food and Drug,Administration (FDA) to market ... device uses near-infrared spectroscopy to,identify lipid core ... arteries,in patients already undergoing cardiac catheterization. Such ...
Other Medicine Technology:BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University 2BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University 3FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries 2FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries 3FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries 4
(Date:12/6/2009)... information and Treatment site www.sleeping-with-a-sleeping-disorder.com is ... herbal or natural sleep aids from around the ... a good cause. The submissions will be compiled ... ,Encyclopedia, by YOU, to be sold from the ... donate 100% of the proceeds ,from sales of ...
(Date:12/6/2009)... Attorney Joseph W. Belluck of Belluck & Fox, LLP says dangerous ... holiday seasons. , ... New York, NY (PRWEB) December ... holiday season, they should be alert to reports of recalls due ... injury lawyer., , ,“Close to 230,000 children visit hospital emergency rooms ...
(Date:12/5/2009)... There have been significant scientific advances in the field ... a better understanding of how certain diseases progress in ... with the best care. Research presented today at the ... explores optimal induction therapies for managing multiple myeloma, the ...
(Date:12/5/2009)... December 5 The first Football,for Hope Centre ... opened its doors,today (5 December 2009). FIFA President ... Helen Zille, 2010 FIFA World Cup Organising Committee,South ... Association,President Kirsten Nematandani and Executive Mayor of the ...
(Date:12/5/2009)... 5 Leukemia and myeloproliferative disorders are serious ... at the 51st Annual Meeting of the American ... and improved diagnostic methods for patients suffering from ... lymphoblastic leukemia, and myelofibrosis that are based on ...
Breaking Medicine News(10 mins):Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9
... relationship of the place of residence to the health of ... consideration of health of the people living in the plains ... 1996 and reviewed after 15 years, especially concerned with coronary ... of two villages in the lowlands and one in the ...
... may lead you to blindness. According to a new research to ... find out a genetic component that may lead to loss of ... blindness due to age, scientists have come up with a gene ... variety of gene that encodes a protein called complement factor H ...
... in developing a computer aided alert program that can predict ... attempts made to prevent the disease before and the current ... researchers are of the opinion that such a prediction may ... hospitalized patients. ,Deep-vein thrombosis or the formation of ...
... Rimonabant (Acomplia) a selective cannabinoid receptor blocker (CB1), can ... with 20 milligrams of rimonabant a day resulted in ... -- a marker of cardiovascularly dangerous visceral fat. It ... of metabolic syndrome in overweight/obese patients. ,The ...
... (“bad” cholesterol) to below 100 milligrams per deciliter by ... safe and results in fewer cardiovascular events. ,The ... 10 milligrams of atorvastatin (Lipitor) a day to get ... a day or lower. Then, half of the patients ...
... conducted in Spain has focused on the increasing incidence ... be associated with an increased risk of cancer in ... has been proven to have disastrous effects on the ... obstetric complications such as extra uterine pregnancy, or pregnancy ...
Other Medicine News:
ISI Micro Brushes are available in a variety of French diameters. Made with stainless steel handles and nylon bristles, the ISI Micro Brushes will last through countless cleanings....
... instrument cleaning brushes in a ... composition. The long, thin brushes ... tubing. The smallest brushes are ... brass and stainless steel brushes ...
... The ISI Brush Nest is the wall organizer ... in a variety of sizes and diameters. Made ... shelf, the ISI Brush Nest is the ultimate ... 18 specialized brushes in a variety of lengths, ...
... stands for Stainless Steel Kleener. SSK-80 is ... and stain remover for ultra-sonic cleaners. , ... of your instruments by removing and inhibiting ... pivot points, box joints and moving instrument ...
Medicine Products: